Patent Application
20220105237
The present invention relates to a film-forming composition, specifically, a film-forming skin protectant and a film-forming skin topical agent.
A liquid adhesive bandage that forms a thin film is considered to be effective for symptoms in which the skin barrier function is deteriorated (hangnail, abrasion, cracking, etc.), and is commercially available for the purpose of protecting skin from kitchen work or the like. However, many of them contain a lower monohydric alcohol such as ethanol or isopropanol in order to enhance quick-drying properties, and have irritation at the time of application. Similarly, in hand eczema, asteatosis, atopic dermatitis and the like in which skin barrier function is deteriorated, affected area often extends over a wider range, and it is difficult to use a film-forming composition containing a lower monohydric alcohol that brings about dryness and irritation of skin. It is desired from patients and medical personnel to develop a film-forming composition that does not contain these lower monohydric alcohols (that is, skin safety is high), in which a film is maintained even by contact with water (that is, protective effect is sustained).
Patent Documents 1 and 2 disclose a topical agent for fingers that forms a soft film when applied to entire fingers, is excellent in quick-drying properties and adhesion to the skin, and can be gently washed off without giving irritation to the skin after use. However, this topical agent for fingers contains a lower monohydric alcohol such as ethanol in terms of quick-drying properties and the like.
Therefore, an object of the present invention is to provide a film-forming composition for skin that is excellent in quick-drying properties and water resistance, is less sticky, and is excellent in feeling of use even without containing a lower monohydric alcohol such as ethanol or isopropanol, specifically, a film-forming skin protectant and a film-forming skin topical agent.
As a result of repeated studies to solve the above problems, the present inventors have found that the above problems can be solved by a combination of a specific acrylic polymer and a plasticizer, and have completed the present invention.
The present invention relates to the following [1] to [10].
[1] A film-forming composition for skin, wherein the composition contains:
(a) one or more acrylic polymers selected from the group consisting of an ethyl acrylate-methyl methacrylate-trimethylammonioethyl methacrylate chloride copolymer, an ethyl acrylate-methyl methacrylate copolymer, a methyl acrylate-methyl methacrylate-methacrylic acid copolymer, and a methacrylic acid-ethyl acrylate copolymer;
(b) one or more plasticizers selected from the group consisting of an ester compound that is liquid at ordinary temperature, an aromatic alcohol that is liquid at ordinary temperature, a medium-polar solid ester compound, and a terpene; and
(c) 36% by weight or more of water based on the total amount of the composition (provided that a propellant is excluded when the composition is an aerosol), and
the composition is substantially free of a lower monohydric alcohol.
[2] The composition according to [1], wherein
the ester compound that is liquid at ordinary temperature is selected from triethyl citrate, triacetin, dibutyl phthalate, diethyl sebacate, diisopropyl sebacate, diisopropyl adipate, and medium-chain triglycerides,
the aromatic alcohol that is liquid at ordinary temperature is selected from ethylene glycol salicylate and phenoxyethanol,
the medium-polar solid ester compound is selected from a phospholipid and a parahydroxybenzoic acid ester, and
the terpene is selected from limonene and menthol.
[3] The composition according to [1], containing at least one plasticizer selected from triethyl citrate, triacetin, dibutyl phthalate, diethyl sebacate, diisopropyl sebacate, diisopropyl adipate, and medium-chain triglycerides.
[4] The composition according to [1], containing at least one plasticizer selected from ethylene glycol salicylate and phenoxyethanol.
[5] The composition according to [1], containing at least one plasticizer selected from a phospholipid and a parahydroxybenzoic acid ester.
[6] The composition according to [1], containing at least one plasticizer selected from limonene and menthol.
[7] The composition according to any one of [1] to [6], wherein the content of the acrylic polymer is 6 to 35% by weight based on the total amount of the composition (provided that a propellant is excluded when the composition is an aerosol).
[8] The composition according to any one of [1] to [7], wherein the content of the plasticizer is 1.3 to 35% by weight based on the total amount of the composition (provided that a propellant is excluded when the composition is an aerosol).
[9] The composition according to any one of [1] to [8], further containing a propellant.
[10] The composition according to any one of [1] to [9], further containing light anhydrous silicic acid and/or titanium oxide.
Since the composition of the present invention is substantially free of a lower monohydric alcohol such as ethanol or isopropanol, the composition has less skin irritation. In addition, since the composition of the present invention contains a large amount (36% by weight or more) of water, it has a fresh (non-sticky) feeling of use. Further, although the composition of the present invention does not contain a lower monohydric alcohol as described above and contains a large amount of water, the composition is excellent in quick-drying properties. Furthermore, a formed film has water resistance, is less sticky, and surprisingly has an excellent effect of suppressing moisture evaporation. The composition of the present invention can be used as a film-forming skin protectant and a film-forming skin topical agent.
The composition of the present invention contains a specific acrylic polymer, a plasticizer and water, and is substantially free of a lower monohydric alcohol such as ethanol or isopropanol. The composition of the present invention can be specifically used as a film-forming skin protectant and a film-forming skin topical agent.
The film-forming skin protectant (not containing a medicinal ingredient) can form a thin film by being sprayed or applied onto skin to effectively protect the skin, and can be used for prevention or treatment of skin diseases such as hand eczema typified by housewife eczema, asteatosis, and atopic dermatitis.
On the other hand, a film-forming skin topical agent (including a medicinal ingredient) forms a film by being sprayed or applied onto skin, and the medicinal ingredient can be effectively delivered into the skin. In addition, the same effect can be expected when the composition is applied to a nail or a skin around the nail or a mucous membrane. This is formulated in a dosage form such as liquid, lotion, gel, cream or aerosol, and can be applied to an antibacterial agent, an antifungal agent, a vitamin agent, an anti-inflammatory agent, an antiallergic agent, a moisturizing agent, a wound therapeutic agent, and the like.
The acrylic polymer used in the present invention is preferably an ethyl acrylate-methyl methacrylate-trimethylammonioethyl methacrylate chloride copolymer, an ethyl acrylate-methyl methacrylate copolymer, a methyl acrylate-methyl methacrylate-methacrylic acid copolymer, or a methacrylic acid-ethyl acrylate copolymer. These polymers are conventionally used as film coating substrates for pharmaceuticals and are known as EUDRAGIT (registered trademark) RS type, EUDRAGIT RL type, EUDRAGIT NE type, EUDRAGIT FS type, and Kollicoat (registered trademark) MAE type.
The acrylic polymer used in the present invention is a water-insoluble acrylic polymer. In the present specification, the water-insoluble acrylic polymer is used to mean not only an acrylic polymer (pH-independent water-insoluble acrylic polymer) that is not dissolved in water regardless of the pH of water but also a pH-dependent water-insoluble acrylic polymer. The pH-dependent water-insoluble acrylic polymer is preferably not dissolved in water at acidic pH (at a pH below 7, especially at a pH below 5.5).
EUDRAGIT RS type is an ethyl acrylate-methyl methacrylate-trimethylammonioethyl methacrylate chloride copolymer, and the composition ratio thereof is 1:2:0.1. EUDRAGIT RS type has an average molecular weight (Mw) of about 32,000 and is pH-independent water-insoluble.
EUDRAGIT RL type is an ethyl acrylate-methyl methacrylate-trimethylammonioethyl methacrylate chloride copolymer, and the composition ratio thereof is 1:2:0.2. EUDRAGIT RL type has an average molecular weight (Mw) of about 32,000 and is pH-independent water-insoluble.
EUDRAGIT NE type is an ethyl acrylate-methyl methacrylate copolymer, and the composition ratio thereof is 2:1. EUDRAGIT NE type has an average molecular weight (Mw) of about 750,000 and is pH-independent water-insoluble.
EUDRAGIT FS type is a methyl acrylate-methyl methacrylate-methacrylic acid copolymer, and the composition ratio thereof is X:Y:1 (where X+Y=10). EUDRAGIT FS type has an average molecular weight (Mw) of about 280,000 and is insoluble in water at a pH below 7.
Kollicoat MAE type is a methacrylic acid-ethyl acrylate copolymer, and the composition ratio thereof is 1:1. Kollicoat MAE type has an average molecular weight (Mw) of about 250,000 and is insoluble in water at a pH below 5.5.
EUDRAGIT RS type is available, for example, as EUDRAGIT RS100, EUDRAGIT RSPO, and EUDRAGIT RS30D (an aqueous suspension containing 30% by weight of ethyl acrylate-methyl methacrylate-trimethylammonioethyl methacrylate chloride copolymer (composition ratio 1:2:0.1)) manufactured by EVONIK (Germany).
EUDRAGIT RL type is available, for example, as EUDRAGIT RL100, EUDRAGIT RLPO, and EUDRAGIT RL30D (an aqueous suspension containing 30% by weight of ethyl acrylate-methyl methacrylate-trimethylammonioethyl methacrylate chloride copolymer (composition ratio 1:2:0.2)) manufactured by EVONIK (Germany).
EUDRAGIT NE type is available, for example, as EUDRAGIT NE30D (an aqueous suspension containing 30% by weight of ethyl acrylate-methyl methacrylate copolymer (composition ratio 2:1)) manufactured by EVONIK (Germany).
EUDRAGIT FS type is available, for example, as EUDRAGIT FS30D (an aqueous suspension containing 30% by weight of methyl acrylate-methyl methacrylate-methacrylic acid copolymer (composition ratio X:Y:1, where X+Y=10)) manufactured by EVONIK (Germany).
Kollicoat MAE type is available, for example, as Kollicoat MAE 30 DP (an aqueous suspension containing 30% by weight of methacrylic acid-ethyl acrylate copolymer (composition ratio 1:1)) manufactured by BASF (Germany).
The content of the polymer based on the total amount of the composition of the present invention (provided that a propellant is excluded when the composition is an aerosol) is preferably 6 to 35% by weight, more preferably 10 to 30% by weight, and particularly preferably 14 to 28% by weight.
The acrylic polymer used in the present invention may be used alone or in combination. Since the composition of the present invention is excellent in water resistance, it need not particularly contain a silicone-based polymer.
The composition of the invention is substantially free of lower monohydric alcohols (monohydric alcohols having 1 to 3 carbon atoms, for example, ethanol, isopropanol, and the like). Substantially free means that a lower monohydric alcohol is not intentionally added in the production process. Therefore, the lower monohydric alcohol content of the composition of the present invention is usually 0% by weight, and even if it is mixed very slightly, the content is less than 1% by weight (more preferably less than 0.5% by weight).
Usually, a lower monohydric alcohol such as ethanol or isopropanol is used to dissolve an acrylic polymer as a film-forming component. However, when used for treatment of a skin disease with deteriorated barrier function such as hand eczema or atopic dermatitis, it is preferable not to contain a lower monohydric alcohol causing skin dryness or irritation. Since the composition of the present invention does not substantially contain a lower monohydric alcohol, the composition has high safety to the skin, and is suitable for treating hand eczema and atopic dermatitis.
Examples of the plasticizer used in the present invention include an ester compound that is liquid at ordinary temperature (25° C.; the same applies hereinafter), an aromatic alcohol that is liquid at ordinary temperature, a medium-polar solid ester compound, and a terpene. These may be used singly or in combination of two or more types thereof.
Preferred examples of the ester compound that is liquid at ordinary temperature include triethyl citrate, triacetin, dibutyl phthalate, diethyl sebacate, diisopropyl sebacate, diisopropyl adipate, and medium-chain triglycerides (for example, glycerin triisooctanoate, tri(caprylic/capric acid) glycerin, and the like).
Fatty acid esters which are selected from diethyl sebacate, diisopropyl sebacate, diisopropyl adipate and medium-chain triglycerides and are liquid at ordinary temperature are more preferable, and among them, diethyl sebacate and diisopropyl adipate are further preferable, and diisopropyl adipate is particularly preferable.
Preferred examples of the aromatic alcohol that is liquid at ordinary temperature include ethylene glycol salicylate and phenoxyethanol.
Examples of the medium-polarity solid ester compound include ester compounds that are solid at ordinary temperature, such as phospholipid (for example, lecithin, especially hydrogenated lecithin) and parahydroxybenzoic acid ester. In the present specification, the medium polarity means that a value according to an organic conceptual diagram is 35° to 55°. The organic conceptual diagram was proposed by Atsushi Fujita, and details thereof are described in “Pharmaceutical Bulletin”, 1954, vol. 2, 2, pp. 163 to 173; “Chemistry region”, 1957, vol. 11, 10, pp. 719 to 725; “Fragrance journal”, 1981, vol. 50, pp. 79 to 82, and the like. That is, a source of all the organic compounds is methane (CH4), and all the other compounds are regarded as derivatives of methane, and certain numerical values are set for a carbon number, substituent, modification part and ring thereof and the like, and the scores are added to determine an organic value and an inorganic value. An angle of inclination when the values are plotted on a diagram in which the organic value is taken on an X-axis and the inorganic value is taken on a Y-axis is the a value.
Examples of combined use of an ester compound that is liquid at ordinary temperature include a combination of a medium-chain triglyceride (for example, glycerin triisooctanoate, tri(caprylic/capric acid) glycerin, and the like), and triethyl citrate, triacetin, dibutyl phthalate, diethyl sebacate, diisopropyl sebacate or diisopropyl adipate.
Examples of combined use of an ester compound that is liquid at ordinary temperature and an aromatic alcohol that is liquid at ordinary temperature include a combination of a medium-chain triglyceride (for example, glycerin triisooctanoate, tri(caprylic/capric acid) glycerin, and the like), and ethylene glycol salicylate or phenoxyethanol.
The content of the plasticizer based on the total amount of the composition of the present invention (provided that a propellant is excluded when the composition is an aerosol) is preferably 1.3 to 35% by weight, more preferably 1.4 to 29% by weight, and particularly preferably 1.4 to 8% by weight. When the amount of the plasticizer is less than 1.3% by weight, film formability and water resistance are deteriorated, and when the amount is more than 35% by weight, the film tends to be sticky, which is not preferable.
The water used in the present invention is particularly preferably purified water. The content of water based on the total amount of the composition of the present invention (provided that a propellant is excluded when the composition is an aerosol) is preferably 36% by weight or more, and more preferably 50% by weight or more. The upper limit is preferably 93% by weight. More specifically, the content is preferably 36 to 92% by weight, more preferably 43 to 89% by weight, particularly preferably 50 to 87% by weight, and further preferably 64 to 85% by weight. EUDRAGIT RS30D, RL30D, NE30D and FS30D, and Kollicoat MAE30DP are all provided as aqueous suspensions containing 30% by weight of an acrylic polymer. Water contained in the aqueous suspensions (corresponding to 70% by weight of the aqueous suspensions) also corresponds to the water used in the present invention.
The composition of the present invention can contain, for example, light anhydrous silicic acid and titanium oxide in order to suppress gloss of the film. The content of the substances based on the total amount of the composition of the present invention (provided that a propellant is excluded when the composition is an aerosol) is preferably 0.8 to 3% by weight, and particularly preferably 1 to 3% by weight.
The composition of the present invention can contain a pH adjusting agent in addition to the above components. Examples of the pH adjusting agent include phosphate, citrate, hydroxide, hydrochloric acid, and the like. The pH adjusting agent may be used singly or in combination of two or more types thereof. The content of the pH adjusting agent based on the total amount of the composition of the present invention (provided that a propellant is excluded when the composition is an aerosol) is preferably 0.01 to 1% by weight, and particularly preferably 0.1 to 0.5% by weight.
When a pH-dependent water-insoluble acrylic polymer is used as the acrylic polymer, it is preferable to adjust the pH of the composition to a pH at which the acrylic polymer is not dissolved.
For example, when EUDRAGIT FS type is used, the pH of the composition is preferably adjusted below 7, and when Kollicoat MAE type is used, the pH of the composition is preferably adjusted below 5.5.
The composition of the present invention can contain, for example, a medicinal ingredient effective for treatment of various skin diseases including chronic skin diseases represented by atopic dermatitis.
Examples of the medicinal ingredient include, but are not limited to, the following ingredients.
The content of the medicinal ingredient based on the total amount of the composition of the present invention (provided that a propellant is excluded when the composition is an aerosol) is preferably 0.01 to 5% by weight, more preferably 0.1 to 1% by weight, and particularly preferably 0.2 to 0.5% by weight.
The composition of the present invention may be an aerosol containing a propellant. Examples of the propellant include dimethyl ether (DME) and a mixture of DME and liquefied natural gas (LPG). More preferred examples of the propellant include DME.
The content of the propellant in the aerosol of the present invention is preferably 30 to 50 parts by weight, more preferably 35 to 50 parts by weight, and particularly preferably 40 to 46 parts by weight, based on 100 parts by weight of the composition excluding the propellant.
The composition of the present invention is useful for the treatment of skin diseases such as hand eczema, asteatosis, and atopic dermatitis. Application amount and application frequency of the composition according to the present invention to the skin may be appropriately adjusted according to skin symptoms, concentration of drug in the composition, age of patient, and the like. Usually, one to several applications per day are appropriate.
Although preferred compound names of essential components and optional components used in the composition of the present invention have been described above, the composition of the present invention also includes compositions obtained by arbitrarily combining these components and compositions obtained by arbitrarily combining the concentration ranges of the respective components. In addition, the numerical ranges such as the concentration can be arbitrarily combined, and when a plurality of numerical ranges is described, the upper limit value or the lower limit value of each numerical range can also be arbitrarily combined.
Hereinafter, the present invention will be described in more detail with reference to examples, but the present invention is not limited to examples.
An ethyl acrylate-methyl methacrylate-trimethylammonioethyl methacrylate chloride copolymer (composition ratio 1:2:0.2) and purified water were weighed, ethylene glycol salicylate was added thereto, and the mixture was stirred until it became uniform.
An ethyl acrylate-methyl methacrylate-trimethylammonioethyl methacrylate chloride copolymer (composition ratio 1:2:0.1) and purified water were weighed, diethyl sebacate was added thereto, and the mixture was stirred until it became uniform. For Formulation Example 3, the same operation was performed without adding diethyl sebacate.
An ethyl acrylate-methyl methacrylate-trimethylammonioethyl methacrylate chloride copolymer (composition ratio 1:2:0.1), a medium-chain triglyceride and purified water were weighed, triethyl citrate, triacetin, diisopropyl adipate, diisopropyl sebacate, diethyl sebacate, ethylene glycol salicylate or phenoxyethanol was added thereto, and the mixture was stirred until it became uniform. The resulting mixture was placed in a pressure-resistant container, and DME was press-fitted into the container to obtain an aerosol.
An ethyl acrylate-methyl methacrylate-trimethylammonioethyl methacrylate chloride copolymer (composition ratio 1:2:0.1) or an ethyl acrylate-methyl methacrylate copolymer (composition ratio 2:1) and purified water were weighed, diethyl sebacate was added thereto, and the mixture was stirred until it became uniform.
An ethyl acrylate-methyl methacrylate-trimethylammonioethyl methacrylate chloride copolymer (composition ratio 1:2:0.1) and purified water were weighed, diethyl sebacate and light anhydrous silicic acid were added thereto, and the mixture was stirred until it became uniform. The resulting mixture was placed in a pressure-resistant container, and DME was press-fitted into the container to obtain an aerosol. For Example 19, the same operation was performed without adding light anhydrous silicic acid.
Formulation Examples shown in Table 7 to Table 12 were prepared using each acrylic polymer according to the preparation method of Formulation Examples 1 to 21 described above. When a pH-dependent water-insoluble acrylic polymer was used as the acrylic polymer, the pH of the composition was adjusted to a range in which the acrylic polymer was insoluble.
Compositions of Formulation Examples are shown in Tables 1 to 12.
The compositions of Formulation Examples 1 to 18 and 22 to 55 were applied to a glass slide at 30° C., the state of film after 2 minutes and 5 minutes was visually observed, and quick-drying properties were evaluated according to the following criteria.
The compositions of Formulation Examples 1 to 18 and 22 to 55 were applied to a glass slide at 30° C. to form a film. Thereafter, the lower half of the glass slide on which the film was formed was infiltrated with water, the state of film after 1 minute and 10 minutes was visually observed, and water resistance was evaluated according to the following criteria.
The compositions of Formulation Examples 1 to 18 and 22 to 55 were applied to a glass slide at 30° C. to form a film. Thereafter, another glass slide was pressed against a film-formed surface of the glass slide, and stickiness (adhesiveness) was evaluated according to the following criteria.
The compositions of Formulation Examples 19 to 21 were applied to artificial leather (76×26 mm) at room temperature, and a film was formed at 30° C. Gloss was evaluated according to the following criteria. The results are shown in Table 5.
A circle having a diameter of 4 cm was opened at the center of a plastic cup lid, and a carrier membrane was attached to this portion (see
After 4 hours at 30° C./40% RH, the amount of water evaporated from the cup of the formulation application group through the carrier membrane was defined as WLX (g/h), the amount of water evaporated from the cup of the formulation non-application group through the carrier membrane was defined as WL0 (g/h), and water evaporation suppression rate (%), which is a value showing an occlusive effect, was calculated using the following formula.
As shown in Table 1, by using a specific acrylic polymer and a specific plasticizer, Formulation Examples 1 and 2 which quickly formed a film (excellent in quick-drying properties) even without containing a lower monohydric alcohol, are excellent in water resistance, are not (or less) sticky, and are excellent in feeling of use were obtained.
As shown in Table 2, it has been revealed that even when diethyl sebacate, which is a fatty acid ester that is liquid at ordinary temperature, is used as a plasticizer, a desired formulation that forms a film quickly, is excellent in water resistance, is not (or less) sticky and is excellent in feeling of use can be obtained.
In addition to diethyl sebacate, it was examined whether a desired film was obtained for an ester compound that is liquid at ordinary temperature. As shown in Table 3, it has been revealed that even when a medium-chain triglyceride is used as a basic component and combined with an ester compound that is liquid at ordinary temperature or an aromatic alcohol which is liquid at ordinary temperature, a desired formulation which forms a film quickly, is excellent in water resistance, is less sticky and is excellent in feeling of use can be obtained.
It was examined whether a desired film was similarly obtained even when the amount of an ethyl acrylate-methyl methacrylate-trimethylammonioethyl methacrylate chloride copolymer (composition ratio 1:2:0.1) was increased or decreased as a water-insoluble acrylic polymer. As shown in Table 4, Formulation Examples 16 and 17 formed a film quickly, were excellent in water resistance, were not (or less) sticky, and were excellent in feeling of use.
Furthermore, it was examined whether a desired film was similarly obtained even with a new ethyl acrylate-methyl methacrylate copolymer (composition ratio 2:1) as a water-insoluble acrylic polymer. As shown in Table 4, Formulation Example 18 using an ethyl acrylate-methyl methacrylate copolymer (composition ratio 2:1) quickly formed a film, was excellent in water resistance, was not sticky, and was excellent in feeling of use.
In general, it is preferable that the topical agent is not conspicuous in appearance at the application site after application of the topical agent. Gloss was considered as one of the factors conspicuous in appearance. Therefore, examinations were made to further reduce the gloss of the film. As shown in Table 5, it was revealed that in Formulation Examples 20 and 21 containing light anhydrous silicic acid, gloss was completely suppressed.
As shown in Table 6, the water evaporation suppression rate (%) of Formulation Example 19 surprisingly showed a high value of 48.4%. The water evaporation suppression rate is one of indices for evaluating the occlusive effect. In skin diseases such as hand eczema, asteatosis and atopic dermatitis, skin barrier function is deteriorated, and the amount of moisture evaporated from the skin is generally large. By application of the present composition, it is expected that the occlusive effect on the skin is obtained, and moisture evaporation from the skin is suppressed, thereby preventing aggravation of symptoms of the above diseases.
It was examined whether a desired film was similarly obtained even when the amounts of the acrylic polymer (ethyl acrylate-methyl methacrylate-trimethylammonioethyl methacrylate chloride copolymer) and the plasticizer (diethyl sebacate) were increased or decreased. As shown in Table 7, Formulation Examples 22 to 29 quickly formed a film, were excellent in water resistance, were not (or less) sticky, and were excellent in feeling of use.
It was examined whether a desired film was similarly obtained even when the amounts of another acrylic polymer (ethyl acrylate-methyl methacrylate copolymer) and the plasticizer (diethyl sebacate) were increased or decreased. As shown in Table 8, Formulation Examples 30 to 33 quickly formed a film, were excellent in water resistance, were not (or less) sticky, and were excellent in feeling of use.
It was examined whether a desired film was similarly obtained even when the amounts of still another acrylic polymer (methacrylic acid-ethyl acrylate copolymer) and the plasticizer (diethyl sebacate) were increased or decreased. As shown in Table 9, Formulation Examples 34 to 38 quickly formed a film, were excellent in water resistance, were not (or less) sticky, and were excellent in feeling of use.
It was examined whether a desired film was similarly obtained even when triethyl citrate was used as a plasticizer and the amount of the acrylic polymer (methyl acrylate-methyl methacrylate-methacrylic acid copolymer) was increased or decreased. As shown in Table 10, Formulation Example 39 to 41 quickly formed a film, were excellent in water resistance, were not sticky, and were excellent in feeling of use.
It was examined whether a desired film was similarly obtained even when the type and/or amount of the plasticizer was changed and/or the amount of the acrylic polymer (ethyl acrylate-methyl methacrylate-trimethylammonioethyl methacrylate chloride copolymer) was increased or decreased. As shown in Tables 11 and 12, Formulation Examples 42 to 55 quickly formed a film, were excellent in water resistance, were not (or less) sticky, and were excellent in feeling of use.
As a result of the above tests, although the composition of the present invention did not contain a lower monohydric alcohol such as ethanol or isopropanol, the composition quickly formed a film, was excellent in water resistance, was not (or less) sticky, and was excellent in feeling of use.
In conventional film-forming skin compositions, a lower monohydric alcohol such as ethanol or isopropanol has been generally used in terms of dissolution of an acrylic polymer as a film-forming component, quick-drying properties (film-forming properties), and the like. In the present invention, elimination of a lower monohydric alcohol has been attempted in terms of skin safety, and as a result of intensive studies, it has been found that a composition for skin excellent in skin safety, which forms a good film in a short time after application even without containing a lower monohydric alcohol. In addition, since the composition of the present invention contains a large amount of water, the composition has a fresh (non-sticky) feeling of use. Further, it was surprisingly confirmed that the formed film had excellent water evaporation suppression ability. The composition of the present invention having an excellent water evaporation suppression ability is extremely useful for treatment of chronic skin diseases (that is, skin diseases in which skin barrier function is deteriorated) represented by hand eczema, atopic dermatitis, and the like.
| Number | Date | Country | Kind |
|---|---|---|---|
| PCT/JP2019/003868 | Feb 2019 | JP | national |
| Filing Document | Filing Date | Country | Kind |
|---|---|---|---|
| PCT/JP2020/003947 | 2/3/2020 | WO | 00 |
